BioMarin Pharmaceutical
BMRN
#1924
Rank
S$13.14 B
Marketcap
S$68.40
Share price
-1.32%
Change (1 day)
-22.80%
Change (1 year)

Market capitalization of BioMarin Pharmaceutical (BMRN)

Market cap: S$13.14 Billion

As of December 2025 BioMarin Pharmaceutical has a market cap of S$13.14 Billion. This makes BioMarin Pharmaceutical the world's 1924th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioMarin Pharmaceutical from 1999 to 2025

End of year Market Cap

Year Marketcap Change
2025S$13.14 B-24.17%
2024S$17.32 B-27.76%
2023S$23.98 B-6.97%
2022S$25.78 B17.58%
2021S$21.92 B4.13%
2020S$21.05 B2.73%
2019S$20.49 B-1.14%
2018S$20.73 B-1%
2017S$20.94 B1.58%
2016S$20.62 B-13.85%
2015S$23.93 B34.4%
2014S$17.80 B39.27%
2013S$12.78 B68.93%
2012S$7.56 B48.85%
2011S$5.08 B32.5%
2010S$3.83 B43.95%
2009S$2.66 B4.92%
2008S$2.54 B-48.63%
2007S$4.94 B114.6%
2006S$2.30 B72.86%
2005S$1.33 B98.34%
2004S$0.67 B-20.51%
2003S$0.84 B28.57%
2002S$0.65 B-49.54%
2001S$1.30 B110.3%
2000S$0.61 B-9.03%
1999S$0.68 B

End of Day market cap according to different sources

On Dec 11th, 2025 the market cap of BioMarin Pharmaceutical was reported to be:

S$13.14 Billion
by Nasdaq info icon info icon
S$13.14 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ultragenyx Pharmaceutical
RARE
S$4.50 B-65.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$0.19 B-98.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$1.24 B-90.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$153.94 B 1,071.53%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
S$3.94 B-70.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
S$3.63 B-72.30%๐Ÿ‡บ๐Ÿ‡ธ USA